WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it is celebrating Men’s Health Month with the launch of the UroLift Patient Ambassador Program, a network of volunteers available to share their personal experiences living with BPH and why the UroLift System was the right treatment option for them. The company also announced that 350,000 patients from around the world have been treated with the UroLift® System,1 a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH), or enlarged prostate.
Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
